Agency Information Collection Activities: Proposed Collection; Comment Request, 18534-18536 [2021-07342]
Download as PDF
18534
Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–07284 Filed 4–8–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2021–0039]
Draft Recommendations for Prevention
and Control of Infections in Neonatal
Intensive Care Unit Patients: Central
Line-Associated Blood Stream
Infections (CLABSI)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (DHHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), in the
Department of Health and Human
Services (DHHS), announces the
opening of a docket to obtain comment
on the Draft Recommendations for
Prevention and Control of Infections in
Neonatal Intensive Care Unit Patients:
Central Line-associated Blood Stream
Infections (CLABSI). (‘‘Draft
Guideline’’). The Draft Guideline
provides new, evidence-based
recommendations specific to the
prevention and control of central lineassociated blood stream infections
(CLABSI) in neonatal intensive care unit
(NICU) patients.
DATES: Written comments must be
received on or before June 8, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0039, by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, Attn: Docket No. CDC–
2021–0039, HICPAC Secretariat, 1600
Clifton Rd. NE, Mailstop H16–2,
Atlanta, Georgia, 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
SUMMARY:
VerDate Sep<11>2014
17:45 Apr 08, 2021
Jkt 253001
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Marwan Wassef, M.P.H., Division of
Healthcare Quality Promotion, National
Center for Emerging and Zoonotic
Infectious Diseases, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H16–2, Atlanta,
Georgia, 30329; Email: IPCGuidelines@
cdc.gov; Telephone: (404) 639–4000.
SUPPLEMENTARY INFORMATION:
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data related to the Draft Guideline.
Please note that comments received,
including attachments and other
supporting materials, are part of the
public record and are subject to public
disclosure. Comments will be posted on
https://www.regulations.gov. Therefore,
do not include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold, submissions containing
private or proprietary information such
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign. CDC will carefully
consider all comments submitted in
preparation of the final Guideline for
Prevention and Control of Infections in
Neonatal Intensive Care Unit Patients
and may revise the final document as
appropriate.
Background
The Draft Guideline, located in the
‘‘Supporting & Related Material’’ tab of
the docket, provides new, evidencebased recommendations specific to the
prevention and control of CLABSI in
NICU patients, including insertion and
maintenance practices.
The Draft Guideline is intended for
use by infection prevention staff,
healthcare epidemiologists, healthcare
administrators, nurses, neonatologists,
other healthcare providers, and persons
responsible for developing,
implementing, and evaluating infection
prevention and control programs for
NICUs. The guideline can also serve as
a resource for societies or organizations
to develop more detailed
implementation guidance for the
prevention of infection in NICU
patients.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
The Healthcare Infection Control
Practices Advisory Committee
(HICPAC), a federal advisory committee
chartered to provide advice and
guidance to the CDC, worked with
national partners, academicians, public
health professionals, healthcare
providers, and other partners to develop
this Draft Guideline. HICPAC includes
representatives from public health,
infectious diseases, regulatory and other
federal agencies, professional societies,
and other stakeholders.
The draft recommendations in this
Draft Guideline are informed by a
systematic review of the best available
literature through February 2017 and of
relevant references published since
February 2017 suggested by subject
matter experts. This Draft Guideline will
not be a federal rule or regulation.
Dated: April 6, 2021.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2021–07337 Filed 4–8–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10209, CMS–
10701, CMS–10516, CMS–855O and CMS–
216–94]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
SUMMARY:
E:\FR\FM\09APN1.SGM
09APN1
Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
June 8, 2021.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: CMS–P–0015A, Room
C4–26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10209 Medicare Advantage
Chronic Care Improvement Program
(CCIP) Attestations
CMS–10701 Medicare Beneficiary
Experiences with Care Survey
(MBECS) System
CMS–10516 Program Integrity II
CMS–855O Medicare Registration
Application
CMS–216–94 Organ Procurement
Organization/Histocompatibility
Laboratory Cost Report
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
VerDate Sep<11>2014
17:45 Apr 08, 2021
Jkt 253001
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage Chronic Care Improvement
Program (CCIP) Attestations; Use:
Section 1852(e) of the Social Security
Act (the Act) requires that Medicare
Advantage (MA) organizations (MAOs)
have an ongoing Quality Improvement
(QI) Program. CMS regulations at 42
CFR 422.152(a) outline the QI Program
requirements for MAOs, which include
the development and implementation of
a Chronic Care Improvement Program
(CCIP) that meets the requirements of
422.152(c) for each contract.
MAOs must use the Health Plan
Management System (HPMS) to report
the status of their CCIP to CMS by
December 31 annually. Submissions
include an attestation by the MAO
regarding its compliance with the
ongoing CCIP requirement (42 CFR
422.152(c)(2)). MAOs are only required
to attest electronically that they are
complying with the ongoing CCIP
requirement. In addition, MAOs should
assess and internally document
activities related to the CCIP on an
ongoing basis, as well as modify
interventions and/or processes as
necessary. A less frequent collection
would not allow CMS to ensure that
annual requirements are being met. This
collection allows CMS to ensure that
annual requirements are still being met,
while also reducing plan burden. Form
Number: CMS–10209 (OMB Control
number: 0938–1023); Frequency:
Annually; Affected Public: Private
Sector—Business or other for-profits;
Number of Respondents: 645; Total
Annual Responses: 645; Total Annual
Hours: 161 (For policy questions
regarding this collection contact Lynn
Pereira at 410–786–2274)
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
18535
2. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Medicare
Beneficiary Experiences with Care
Survey (MBECS) System; Use: The
MBECS system is designed to conduct
population specific surveys that will be
administered to the group of interest,
fielded one time. This means that over
the three-year period, two individual
surveys will be administered. This will
allow CMS OMH to respond quickly to
the data needs of stakeholders with
interests in these underrepresented
groups. Data collected through the
MBECS system will be used to better
understand—and thus serve the needs
of—Medicare beneficiaries in minority
populations. The core questionnaire
will collect information on
communication with medical
professionals, coordination of health
care, experiences getting needed health
care, experiences with personal doctors
and specialists, and key demographics.
Data will be compared to benchmarks
from the FFS CAHPS, MA CAHPS, and
NAM CAHPS surveys. The populationspecific questionnaire module described
and submitted via a specific collection
request will collect information about
issues most relevant for that particular
group of interest.
The goal of this umbrella data
collection effort is to gather data via
separate surveys on a variety of minority
Medicare beneficiaries’ experiences.
Topics and questions of interest may ask
about beneficiaries’ communication
with medical professionals,
coordination of health care, experiences
getting needed health care, and
experiences with personal doctors and
specialists. CMS OMH will compare
survey data to benchmarks from the
general population of Medicare
beneficiaries while controlling for
population characteristics, as
appropriate.
Survey respondents will have the
opportunity to respond to an MBECS
survey via a self-administered webbased survey (also called computerassisted web interview or CAWI). CAWI
technology minimizes respondent
burden by (1) Automatically providing
text fills within questions and handling
skip patterns based on responses to each
question; (2) allowing respondents to
complete the survey at a convenient
time; (3) allowing respondents to stop
and re-enter the survey if needed; and
(4) capturing data in real-time, thereby
eliminating the need for manual data
entry. Form Number: CMS–10701 (OMB
Control number: 0938–New); Frequency:
Annually; Affected Public: Individuals
and Households; Number of
E:\FR\FM\09APN1.SGM
09APN1
18536
Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices
Respondents: 13,000; Total Annual
Responses: 13,000; Total Annual Hours:
4,290 (For policy questions regarding
this collection contact Luis Pons Perez
at 410–786–8557)
3. Type of Information Collection:
Extension of a currently approved
collection; Title of Information
Collection: Program Integrity II; Use: On
June 19, 2013, HHS published proposed
rule CMS–9957–P: Program Integrity:
Exchanges, SHOP, Premium
Stabilization Programs, and Market
Standards (78 FR 37302) (Program
Integrity Proposed Rule) which, among
other things, contained third party
disclosure requirements and data
collections that supported the oversight
of premium stabilization programs,
State Exchanges, and qualified health
plan (QHP) issuers in Federallyfacilitated Exchanges (FFEs). Parts of the
proposed rule were finalized as Patient
Protection and Affordable Care Act;
Program Integrity: Exchange, Premium
Stabilization Programs, and Market
Standards; Amendments to the HHS
Notice of Benefit and Payment
Parameters for 2014; Final Rule
(Program Integrity Final Rule II), 78 FR
25326 (October 24, 2013). This ICR
relates to a portion of the information
collection request (ICR) requirements set
forth in the final rule. Form Number:
CMS–10516 (OMB control number:
0938–1277); Frequency: Annually;
Affected Public: Private Sector, State,
Business, and Not-for Profits; Number of
Respondents: 428; Number of
Responses: 428; Total Annual Hours:
40,420. (For questions regarding this
collection, contact Joshua Van Drei at
(410–786–1659).
4. Type of Information Collection
Request: Revision of a currently
approved information collection; Title
of Information Collection: Medicare
Registration Application; Use:
Physicians and practitioners complete
the Medicare Enrollment Application—
Enrollment for Eligible Ordering,
Certifying Physicians and Other Eligible
Professionals if they are enrolling in
Medicare not to obtain Medicare billing
privileges but strictly to order, refer, or
certify certain Medicare items and
services. It is used by Medicare
contractors to collect data that helps
ensure the applicant has the necessary
credentials to order and certify certain
Medicare items and services.
The MAC establishes Medicare
Identification Numbers. The MACs store
these numbers and information in CMS’
Provider Enrollment, Chain and
Ownership System (PECOS). The
application is used by the CMS’
contractors to collect data ensures that
the applicant has the necessary
VerDate Sep<11>2014
17:45 Apr 08, 2021
Jkt 253001
information for unique identification.
The license numbers are validated
against state licensing websites. All the
license numbers are captured and stored
in the MAC database. Social Security
Numbers (SSNs) are validated against
the Social Security Administration
database (SSA) and only the valid
entries are allowed to proceed in the
process of getting a Medicare billing
number. Correspondence address and
contact information is captured to
contact the provider/supplier.
The collection and verification of this
information defends and protects our
beneficiaries from illegitimate
providers/suppliers. These procedures
also protect the Medicare Trust Fund
against fraud. It gathers information that
allow Medicare contractors to ensure
that the physician or eligible
professional is not sanctioned from the
Medicare and/or Medicaid program(s),
or debarred, or excluded from any other
Federal agency or program. The data
collected also ensures that the applicant
has the necessary credentials to order
and certify health care services. This is
sole instrument implemented for this
purpose. Form Number: CMS–855O
(OMB Control Number: 0938–1135);
Frequency: Occasionally; Affected
Public: Private Sector (Business or other
for-profits), State, Local, or Tribal
Governments; Number of Respondents:
448,000; Number of Responses: 24,000;
Total Annual Hours: 243,600. (For
questions regarding this collection
contact Kimberly McPhillips (410–786–
8438.)
5. Type of Information Collection
Request: Reinstatement without change
of a previously approved collection;
Title of Information Collection: Organ
Procurement Organization
Histocompatibility Laboratory Cost
Report; Use: The Form CMS–216–94
cost report is needed to determine
Organ Procurement Organization (OPO)/
Histocompatibility Lab (HL) reasonable
costs incurred in procuring and
transporting organs for transplant into
Medicare beneficiaries and
reimbursement due to or from the
provider. The reasonable costs of
procuring and transporting organs
cannot be determined for the fiscal year
until the OPO/HL files its cost report
and costs are verified by the Medicare
contractor. During the fiscal year, an
interim rate is established based on cost
report data from the previous year. The
OPO/HL bills the transplant hospital for
services rendered. The transplant
hospital pays interim payments,
approximating reasonable cost, to the
OPO/HL. The Form CMS–216–94 cost
report is filed by each OPO/HL at the
end of its fiscal year and there is a cost
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
report settlement to take into account
increases or decreases in costs. The cost
report reconciliation and settlement take
into consideration the difference
between the total reasonable costs
minus the total interim payments
received or receivable from the
transplant centers. Form Number: CMS–
216–94 (OMB Control number: 0938–
0102); Frequency: Annually; Affected
Public: Private Sector—Business or
other for-profits; Number of
Respondents: 95; Total Annual
Responses: 95; Total Annual Hours:
4,275 (For policy questions regarding
this collection contact Luann Piccione
at 410–786–5423)
Dated: April 6, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2021–07342 Filed 4–8–21; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Availability of Program Application
Instructions for the Title VII, Part C of
the Act, Centers for Independent
Living (CILs) To Expand COVID–19
Vaccine Access for People With
Disabilities
Title: Expanding Disabilities
Network’s (CILs) Access to COVID–19
Vaccines.
Announcement Type: Initial.
Statutory Authority: The statutory
authority for grants under this program
announcement is contained in Section
711 and Section 712 of the
Rehabilitation Act of 1973 [Pub. L. 93–
112] [As Amended Through Pub. L.
114–95, Enacted December 10, 2015].
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.432.
DATES: The deadline date for the
submission of the Expanding
Disabilities Network’s (CILs) Access to
COVID–19 Vaccines is 11:59 p.m.
Eastern Time April 23, 2021.
I. Funding Opportunity Description
The Administration for Community
Living (ACL) announced a new funding
opportunity to increase vaccine access
for people with disabilities. With
funding and partnership support from
the Centers for Disease Control (CDC),
ACL is providing grants to disability
networks to provide critical services to
help communities combat COVID–19. A
leading priority of this joint effort is to
E:\FR\FM\09APN1.SGM
09APN1
Agencies
[Federal Register Volume 86, Number 67 (Friday, April 9, 2021)]
[Notices]
[Pages 18534-18536]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07342]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10209, CMS-10701, CMS-10516, CMS-855O and
CMS-216-94]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and
[[Page 18535]]
clarity of the information to be collected, and the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
DATES: Comments must be received by June 8, 2021.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: CMS-P-0015A, Room C4-26-05, 7500 Security Boulevard,
Baltimore, Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10209 Medicare Advantage Chronic Care Improvement Program (CCIP)
Attestations
CMS-10701 Medicare Beneficiary Experiences with Care Survey (MBECS)
System
CMS-10516 Program Integrity II
CMS-855O Medicare Registration Application
CMS-216-94 Organ Procurement Organization/Histocompatibility Laboratory
Cost Report
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Advantage Chronic Care Improvement Program (CCIP) Attestations; Use:
Section 1852(e) of the Social Security Act (the Act) requires that
Medicare Advantage (MA) organizations (MAOs) have an ongoing Quality
Improvement (QI) Program. CMS regulations at 42 CFR 422.152(a) outline
the QI Program requirements for MAOs, which include the development and
implementation of a Chronic Care Improvement Program (CCIP) that meets
the requirements of 422.152(c) for each contract.
MAOs must use the Health Plan Management System (HPMS) to report
the status of their CCIP to CMS by December 31 annually. Submissions
include an attestation by the MAO regarding its compliance with the
ongoing CCIP requirement (42 CFR 422.152(c)(2)). MAOs are only required
to attest electronically that they are complying with the ongoing CCIP
requirement. In addition, MAOs should assess and internally document
activities related to the CCIP on an ongoing basis, as well as modify
interventions and/or processes as necessary. A less frequent collection
would not allow CMS to ensure that annual requirements are being met.
This collection allows CMS to ensure that annual requirements are still
being met, while also reducing plan burden. Form Number: CMS-10209 (OMB
Control number: 0938-1023); Frequency: Annually; Affected Public:
Private Sector--Business or other for-profits; Number of Respondents:
645; Total Annual Responses: 645; Total Annual Hours: 161 (For policy
questions regarding this collection contact Lynn Pereira at 410-786-
2274)
2. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection:
Medicare Beneficiary Experiences with Care Survey (MBECS) System; Use:
The MBECS system is designed to conduct population specific surveys
that will be administered to the group of interest, fielded one time.
This means that over the three-year period, two individual surveys will
be administered. This will allow CMS OMH to respond quickly to the data
needs of stakeholders with interests in these underrepresented groups.
Data collected through the MBECS system will be used to better
understand--and thus serve the needs of--Medicare beneficiaries in
minority populations. The core questionnaire will collect information
on communication with medical professionals, coordination of health
care, experiences getting needed health care, experiences with personal
doctors and specialists, and key demographics. Data will be compared to
benchmarks from the FFS CAHPS, MA CAHPS, and NAM CAHPS surveys. The
population-specific questionnaire module described and submitted via a
specific collection request will collect information about issues most
relevant for that particular group of interest.
The goal of this umbrella data collection effort is to gather data
via separate surveys on a variety of minority Medicare beneficiaries'
experiences. Topics and questions of interest may ask about
beneficiaries' communication with medical professionals, coordination
of health care, experiences getting needed health care, and experiences
with personal doctors and specialists. CMS OMH will compare survey data
to benchmarks from the general population of Medicare beneficiaries
while controlling for population characteristics, as appropriate.
Survey respondents will have the opportunity to respond to an MBECS
survey via a self-administered web-based survey (also called computer-
assisted web interview or CAWI). CAWI technology minimizes respondent
burden by (1) Automatically providing text fills within questions and
handling skip patterns based on responses to each question; (2)
allowing respondents to complete the survey at a convenient time; (3)
allowing respondents to stop and re-enter the survey if needed; and (4)
capturing data in real-time, thereby eliminating the need for manual
data entry. Form Number: CMS-10701 (OMB Control number: 0938-New);
Frequency: Annually; Affected Public: Individuals and Households;
Number of
[[Page 18536]]
Respondents: 13,000; Total Annual Responses: 13,000; Total Annual
Hours: 4,290 (For policy questions regarding this collection contact
Luis Pons Perez at 410-786-8557)
3. Type of Information Collection: Extension of a currently
approved collection; Title of Information Collection: Program Integrity
II; Use: On June 19, 2013, HHS published proposed rule CMS-9957-P:
Program Integrity: Exchanges, SHOP, Premium Stabilization Programs, and
Market Standards (78 FR 37302) (Program Integrity Proposed Rule) which,
among other things, contained third party disclosure requirements and
data collections that supported the oversight of premium stabilization
programs, State Exchanges, and qualified health plan (QHP) issuers in
Federally-facilitated Exchanges (FFEs). Parts of the proposed rule were
finalized as Patient Protection and Affordable Care Act; Program
Integrity: Exchange, Premium Stabilization Programs, and Market
Standards; Amendments to the HHS Notice of Benefit and Payment
Parameters for 2014; Final Rule (Program Integrity Final Rule II), 78
FR 25326 (October 24, 2013). This ICR relates to a portion of the
information collection request (ICR) requirements set forth in the
final rule. Form Number: CMS-10516 (OMB control number: 0938-1277);
Frequency: Annually; Affected Public: Private Sector, State, Business,
and Not-for Profits; Number of Respondents: 428; Number of Responses:
428; Total Annual Hours: 40,420. (For questions regarding this
collection, contact Joshua Van Drei at (410-786-1659).
4. Type of Information Collection Request: Revision of a currently
approved information collection; Title of Information Collection:
Medicare Registration Application; Use: Physicians and practitioners
complete the Medicare Enrollment Application--Enrollment for Eligible
Ordering, Certifying Physicians and Other Eligible Professionals if
they are enrolling in Medicare not to obtain Medicare billing
privileges but strictly to order, refer, or certify certain Medicare
items and services. It is used by Medicare contractors to collect data
that helps ensure the applicant has the necessary credentials to order
and certify certain Medicare items and services.
The MAC establishes Medicare Identification Numbers. The MACs store
these numbers and information in CMS' Provider Enrollment, Chain and
Ownership System (PECOS). The application is used by the CMS'
contractors to collect data ensures that the applicant has the
necessary information for unique identification. The license numbers
are validated against state licensing websites. All the license numbers
are captured and stored in the MAC database. Social Security Numbers
(SSNs) are validated against the Social Security Administration
database (SSA) and only the valid entries are allowed to proceed in the
process of getting a Medicare billing number. Correspondence address
and contact information is captured to contact the provider/supplier.
The collection and verification of this information defends and
protects our beneficiaries from illegitimate providers/suppliers. These
procedures also protect the Medicare Trust Fund against fraud. It
gathers information that allow Medicare contractors to ensure that the
physician or eligible professional is not sanctioned from the Medicare
and/or Medicaid program(s), or debarred, or excluded from any other
Federal agency or program. The data collected also ensures that the
applicant has the necessary credentials to order and certify health
care services. This is sole instrument implemented for this purpose.
Form Number: CMS-855O (OMB Control Number: 0938-1135); Frequency:
Occasionally; Affected Public: Private Sector (Business or other for-
profits), State, Local, or Tribal Governments; Number of Respondents:
448,000; Number of Responses: 24,000; Total Annual Hours: 243,600. (For
questions regarding this collection contact Kimberly McPhillips (410-
786-8438.)
5. Type of Information Collection Request: Reinstatement without
change of a previously approved collection; Title of Information
Collection: Organ Procurement Organization Histocompatibility
Laboratory Cost Report; Use: The Form CMS-216-94 cost report is needed
to determine Organ Procurement Organization (OPO)/Histocompatibility
Lab (HL) reasonable costs incurred in procuring and transporting organs
for transplant into Medicare beneficiaries and reimbursement due to or
from the provider. The reasonable costs of procuring and transporting
organs cannot be determined for the fiscal year until the OPO/HL files
its cost report and costs are verified by the Medicare contractor.
During the fiscal year, an interim rate is established based on cost
report data from the previous year. The OPO/HL bills the transplant
hospital for services rendered. The transplant hospital pays interim
payments, approximating reasonable cost, to the OPO/HL. The Form CMS-
216-94 cost report is filed by each OPO/HL at the end of its fiscal
year and there is a cost report settlement to take into account
increases or decreases in costs. The cost report reconciliation and
settlement take into consideration the difference between the total
reasonable costs minus the total interim payments received or
receivable from the transplant centers. Form Number: CMS-216-94 (OMB
Control number: 0938-0102); Frequency: Annually; Affected Public:
Private Sector--Business or other for-profits; Number of Respondents:
95; Total Annual Responses: 95; Total Annual Hours: 4,275 (For policy
questions regarding this collection contact Luann Piccione at 410-786-
5423)
Dated: April 6, 2021.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2021-07342 Filed 4-8-21; 8:45 am]
BILLING CODE 4120-01-P